- Bevorzugter Name
- Linagliptin Impurity 44
- IUPAC
- 1-N,2-N-bis[(3R)-1-[7-but-2-ynyl-3-methyl-1-[(4-methylquinazolin-2-yl)methyl]-2,6-dioxopurin-8-yl]piperidin-3-yl]benzene-1,2-dicarboxamide
- Englischer Name
- Linagliptin Impurity 29
- Summenformel
- C58H58N16O6
- Molmasse
- 1075.21
Namen und Synonyme
2074688-82-5N1,N2-Bis[(3R)-1-[7-(2-butyn-1-yl)-2,3,6,7-tetrahydro-3-methyl-1-[(4-methyl-2-quinazolinyl)methyl]-2,6-dioxo-1H-purin-8-yl]-3-piperidinyl]-1,2-benzenedicarboxamideLinagliptin Impurity 44Linagliptin Impurity WN1,N2-bis((R)-1-(7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)phthalamide6Z446DY8FH1,2-Benzenedicarboxamide, N1,N2-bis[(3R)-1-[7-(2-butyn-1-yl)-2,3,6,7-tetrahydro-3-methyl-1-[(4-methyl-2-quinazolinyl)methyl]-2,6-dioxo-1H-purin-8-yl]-3-piperidinyl]-Linagliptin Impurity 291-methyl-3-((4-methylquinazolin-2-yl)methyl)imidazolidine-2,4,5-trione
Datenbank-Bezeichner
- PubChem CID
- 175673489
- UNII
- 6Z446DY8FH